Tetra Radar · FDA Approvals · Decision date
mezigdomide: FDA decision date
Bristol Myers Squibb Co (BMY) · 13 May 2027
Mezigdomide PDUFA: May 13, 2027 Positive Pivotal Data Readouts Achieved.
Source: 8-K of 29 October 2026
The decision is pending.
Bristol Myers Squibb Co on Tetra Radar
A PDUFA date is the date by which the FDA has said it will decide on an application. Dates can move, and a decision is not an approval. Tetra Radar observes public information for research purposes. It does not provide investment advice.